In addition, some subtypes of pediatric and young adult high‐grade gliomas, including those with MN1 alterations, MYCN amplifications, and H3‐3A G34 mutations, may be histologically indistinguishable from CNS embryonal tumors.2 The gene discussed is MN1; the disease is central nervous system cancer.